Evidence map›Paper›PMID 35501336›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2022

The characteristics and clinical significance of atypical mitosis in breast cancer.

Ayat Lashen, Michael S Toss, Mansour Alsaleem, Andrew R Green, Nigel P Mongan, Emad Rakha

Open access · hybridAbstract read
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. A survey of chromosomal instability measures across mechanistic models.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Article
  8. Article
  9. A survey of CIN measures across mechanistic models.bioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 4 countries.

Ayat LashenAcademic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
Michael S TossAcademic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
Mansour AlsaleemAcademic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0002-7689-2493
Andrew R GreenAcademic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0002-0488-5913
Nigel P MonganSchool of Veterinary Medicine and Sciences, University of Nottingham, Nottingham, UK.ORCID 0000-0001-5438-1126
Emad RakhaAcademic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK. emad.rakha@nottingham.ac.uk.
University of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atypical mitosis is considered a feature of malignancy, however, its significance in breast cancer (BC) remains elusive. Here, we aimed to assess the clinical value of atypical mitoses in BC and to explore their underlying molecular features. Atypical and typical mitotic figures were quantified and correlated with clinicopathological variables in a large cohort of primary BC tissue sections (n = 846) using digitalized hematoxylin and eosin whole-slide images (WSIs). In addition, atypical mitoses were assessed in The Cancer Genome Atlas (TCGA) BC dataset (n = 1032) and were linked to the genetic alterations and pathways. In this study, the median of typical mitoses was 17 per 3 mm

Indexed as

Breast NeoplasmsTriple Negative Breast NeoplasmsEosine Yellowish-(YS)FemaleHematoxylinHumansMitosisPrognosisEosine Yellowish-(YS)Hematoxylin

Identifiers

PMID35501336
PMCPMC9514994
OpenAlexW4225276367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.